WATER is committed to linking the provision of water and sanitation to the treatment of Buruli Ulcer (BU) and other NTDs in West Africa. Beginning in late 2012, a drug trial will take place in Ghana during which many people will drive back into the rural areas looking for cases. The purpose of the drug trial is to test the replacement of Streptomycin (injected) with Clarithromycin (oral) as one of two drugs used to treat BU. WATER's involvement is in surveillance as well as to upgrade water and sanitation systems at Buruli Ulcer treatment wards in trial hospitals. We know that severe cases of BU (a flesh eating bacteria) will be found and require surgery. The study will last 3 years and we expect to find at least 150 to 200 patients who will require skin grafts and other types of surgery (see news below for more information on the drug trial). The drug trial will provide the drugs but someone has to pay for the surgeries when severely affected patients are found. We need your help. You can participate by going to Donate Now and ask other people to donate while noting that it is for "Buruli Surgeries". Thanks.
Water In Africa Through Everyday Responsiveness - WATER is pleased to announce that Minta Aboagye has joined its Board of Directors. Mr. Aboagye brings a vast amount of Water and Sanitation experience to WATER, having spent 34 years at the Ministry of Water Resources, Works and Housing in Ghana. The last 9 he was the Director of Water and as such directed both Ghana Water Company (urban water) and Community Water and Sanitation (rural water) in the country unitil his retirement in December, 2010. Mr. Aboagye adds his considerable expertise to the effort to link the provision of water and sanitation to health issues, especially neglected tropical disease.